Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosome binding domain 1 pseudogene 28 (HMGN1P28) is a human processed pseudogene related to the high mobility group nucleosome binding domain 1 (HMGN1) gene[3]. Pseudogenes such as HMGN1P28 typically arise by duplication or retrotransposition events and lack the ability to encode a functional protein. Some pseudogenes in related families have been shown to play regulatory roles in cell biology, such as acting as decoys for microRNAs or generating regulatory non-coding RNAs[4][5]; however, for HMGN1P28 specifically, no biological function, disease association, or therapeutic relevance has been reported to date. There are no known drugs, biomarkers, or therapeutic mechanisms associated with HMGN1P28.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 28 (HMGN1P28).